Literature DB >> 1584770

Immunostimulatory human urinary protein.

E Fontan1, H Saklani-Jusforgues, R M Fauve.   

Abstract

We have previously extracted a protein from inflammatory mouse granuloma that fully protects normal mice against lethal Listeria monocytogenes infection. We now report that polyclonal antibodies directed against this protein react with a human urinary fraction that also provides full protection of normal mice against L. monocytogenes. Murine monoclonal antibodies completely inhibit the protective activity of the human urinary fraction. We have purified to apparent homogeneity a human glycoprotein of 43 kDa (HGP.43), pI = 3.2 +/- 0.2. HGP.43 injected i.v. at 250 micrograms/kg fully protected mice against a lethal inoculum of L. monocytogenes. Such resistance followed injection of HGP.43, 4 days before and, still significantly, 8 hr after Listeria infection. In scid mice lacking T and B cells, similar resistance to L. monocytogenes was observed. Inflammatory murine macrophages became cytostatic against Lewis carcinoma cells after incubation with 1.5 nM HGP-43.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1584770      PMCID: PMC49081          DOI: 10.1073/pnas.89.10.4358

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Evidence that tumor necrosis factor has an important role in antibacterial resistance.

Authors:  E A Havell
Journal:  J Immunol       Date:  1989-11-01       Impact factor: 5.422

2.  Increased phagocytic activity in mice treated by a mouse granuloma protein.

Authors:  E Fontan; R M Fauve
Journal:  Ann Inst Pasteur Immunol       Date:  1986 Jul-Aug

3.  Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon.

Authors:  A F Kiderlen; S H Kaufmann; M L Lohmann-Matthes
Journal:  Eur J Immunol       Date:  1984-10       Impact factor: 5.532

4.  Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection.

Authors:  A Nakane; T Minagawa; K Kato
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

5.  Anti-tumor effects of recombinant human macrophage colony-stimulating factor, alone or in combination with local irradiation, in mice inoculated with Lewis lung carcinoma cells.

Authors:  L Lu; R N Shen; Z H Lin; S L Aukerman; P Ralph; H E Broxmeyer
Journal:  Int J Cancer       Date:  1991-01-02       Impact factor: 7.396

6.  Characterization of a high-molecular-weight form of epidermal growth factor in an extract of human urine.

Authors:  C D Mount; T J Lukas; D N Orth
Journal:  Arch Biochem Biophys       Date:  1987-05-15       Impact factor: 4.013

7.  Inflammation and anti-tumor resistance. IV. Induction of cytostatic activity of murine peritoneal cells by a mouse granuloma protein.

Authors:  E Fontan; R M Fauve
Journal:  Int J Cancer       Date:  1988-08-15       Impact factor: 7.396

8.  Recombinant murine granulocyte-macrophage colony-stimulating factor augments neutrophil recovery and enhances resistance to infections in myelosuppressed mice.

Authors:  P Mayer; E Schütze; C Lam; F Kricek; E Liehl
Journal:  J Infect Dis       Date:  1991-03       Impact factor: 5.226

9.  Cellular mediators of anti-Listeria immunity as an enlarged population of short lived, replicating T cells. Kinetics of their production.

Authors:  R J North
Journal:  J Exp Med       Date:  1973-08-01       Impact factor: 14.307

10.  Cellular resistance to infection.

Authors:  G B MACKANESS
Journal:  J Exp Med       Date:  1962-09-01       Impact factor: 14.307

View more
  2 in total

1.  A 92-kDa human immunostimulatory protein.

Authors:  E Fontan; E Briend; H Saklani-Jusforgues; J d'Alayer; J Vandekerckhove; R M Fauve
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

2.  Randomized phase II clinical trial of chemo-immunotherapy in advanced nonsmall cell lung cancer.

Authors:  Eduardo Lasalvia-Prisco; Emilio Garcia-Giralt; Jesús Vázquez; Marta Aghazarian; Eduardo Lasalvia-Galante; Joshemaria Larrañaga; Gonzalo Spera
Journal:  Biologics       Date:  2008-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.